Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: Preliminary human studies

Lasers in Surgery and Medicine

Volumn 31, Issue 1, 2002, Pages 18-22

  Wilder Smith, Clive H ^a,g   Wilder Smith, Petra ^b   Grosjean, Pierre ^c   Van Den Bergh, Hubert ^d   Woodtli, Alain ^e   Monnier, Philippe ^c   Dorta, Gian ^c   Meister, Friedrich ^f   Wagnières, Georges ^d  

^a Nociception Research Group   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d EPFL   (Switzerland)

^e Medlight SA   (Switzerland)

^f Pathology Institute Länggasse   (Switzerland)

^g Gastroenterology Group Practice   (Switzerland)

Author keywords

Aminolevulinic acid (ALA); Antibacterial therapy; Gastritis; Helicobacter pylori; Human; Laser; Photodynamic therapy; Photosensitizer

Indexed keywords

ALAT AG; AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CLINICAL ARTICLE; DOSIMETRY; ERADICATION THERAPY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY; TREATMENT OUTCOME; BIOPSY; CLINICAL TRIAL; DRUG EFFECT; GASTROSCOPY; HELICOBACTER INFECTION; LIGHT; LOW LEVEL LASER THERAPY; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PEPTIC ULCER; PHOTOTHERAPY; RADIATION EXPOSURE; STOMACH; TIME;

ADULT; AMINOLEVULINIC ACID; BIOPSY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; LASER THERAPY, LOW-LEVEL; LIGHT; MALE; MIDDLE AGE; PEPTIC ULCER; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; STOMACH; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; HUMANS; MIDDLE AGED;

EID: 0035992569     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10066     Document Type: Article

References (27)

1. Helicobacter pylori
2. Helicobacter pylori and gastric cancer
3. Helicobacter pylori - Not a good bug after all
4. Photodynamic antimicrobial chemotherapy (PACT)
5. Photodynamic destruction of Haemophilus parainfluenzae by endogenously produced porphyrins
6. The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitizer
7. Light dosimetry in PDT for Helicobacter pylori
8. Photosensitisation of Helicobacter pylori with 5-aminolaevulinic acid
9. Diagnosis of Campylobacter pylori infections: The gold standard and the alternatives
10. Mathematical description of photobleaching in vivo describing the influence of tissue optics on measured fluorescence signals
11. Systems for light application and dosimetry in photodynamic therapy
12. Photodynamic therapy and the alimentary tract
13. Photodynamic therapy. Recent Results
14. Photodynamic therapy
15. Review article: The potential role for photodynamic therapy in the management of upper gastrointestinal disease
16. Photodynamic therapy in oncology
17. Mechanisms of tumor necrosis induced by photodynamic therapy
18. Photodynamic therapy: Shedding light on the biochemical pathways regulating porphyrin-mediated cell death
19. Effects of photoactivated HPD on bacteria and antibiotic resistance
20. Bactericidal effects of photoactivated porphyrins-an alternative approach to antimicrobial drugs
21. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori
22. Reliability of biopsy-based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication
23. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results
24. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacterpylori
25. Lanzoprazole versus lansoprazole plus amoxycillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer
26. Symptoms and risk factors of H. pylori infection in a cohort of epidemiologists
27. Oral versus intravenous administration of 5-aminolaevulanic acid for photodynamic therapy